Indrayani Biotech Ltd (526445) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 526445 | NSE: | Floriculture | Small Cap

Indrayani Biotech Share Price

14 0.00 0.00%
as on 05-Dec'25 16:59

Indrayani Biotech Ltd (526445) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 526445 | NSE: | Floriculture | Small Cap

DeciZen - make an informed investing decision on Indrayani Biotech

Based on:

M-Cap below 100cr DeciZen not available

Indrayani Biotech stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
44.18
Market Cap:
63.8 Cr.
52-wk low:
10.2
52-wk high:
38

Is Indrayani Biotech Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Indrayani Biotech: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Indrayani Biotech Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % -3.7%-5.9%0%0%0%-50.7%16%12.5%8%7%-
Value Creation
Index
-1.3NANANANA-4.60.2-0.1-0.4-0.5-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 00000.5215874.562.337.834
Sales YoY Gr.-NANANANA4,102%176%28.4%-16.3%-39.4%-
Adj EPS -0.4-0.3-0.3-0.2-0.6-2.31.21.60.30.30.3
YoY Gr.-NANANANANANA28.5%-79.8%0%-
BVPS (₹) 8.6-1.3-1.7-1.8-2.45.87.111.811.111.411.4
Adj Net
Profit
-0.1-0.1-0.1-0.1-0.2-84.25.41.51.51
Cash Flow from Ops. -0.1-0.1-0.1-0.20.10.53.58.326.117.4-
Debt/CF from Ops. -3-4.6-5.1-3.18.729.84.84.22.33.6-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA137.5%-13.3%-39.4%
Adj EPS NANA-36.2%0%
BVPS3.2%NA17.3%2.9%
Share Price 4% 9.8% -47% -62.1%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
-4.1-7.8238.627.1-83.919.214.42.82.62.8
Op. Profit
Mgn %
0000-30.8-22.210.811.79.314.714.9
Net Profit
Mgn %
0000-41-38.17.37.32.33.84.3
Debt to
Equity
0.1-1-1-1-0.80.80.70.71.21.2-
Working Cap
Days
0000499093182386786390
Cash Conv.
Cycle
0000-1012228569611491

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Indrayani Biotech Ltd.

Standalone Consolidated
TTM EPS (₹) 0.3 -1.7
TTM Sales (₹ Cr.) 33.7 128
BVPS (₹.) 11.4 15.2
Reserves (₹ Cr.) 6 24
P/BV 1.23 0.92
PE 44.18 0.00
From the Market
52 Week Low / High (₹) 10.20 / 37.99
All Time Low / High (₹) 0.50 / 115.70
Market Cap (₹ Cr.) 63.8
Equity (₹ Cr.) 45.5
Face Value (₹) 10
Industry PE 72.3

Management X-Ray of Indrayani Biotech:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.0014.9815.0215.0618.0824.6124.612.46
* Pledged shares as % of Promoter's holding (%)

Valuation of Indrayani Biotech - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Indrayani Biotech

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales00000.5021.0157.9974.4862.3237.77
Operating Expenses 0.130.100.120.210.6625.6851.7565.7656.5232.22
Manufacturing Costs000000.330.340.631.020.43
Material Costs00000.5015.7639.7141.4935.1514.78
Employee Cost 0.020.030.040.030.035.228.4817.1015.2312.86
Other Costs 0.110.080.090.180.134.363.226.545.124.15
Operating Profit -0.13-0.10-0.12-0.21-0.15-4.676.248.725.805.55
Operating Profit Margin (%) -----30.8%-22.2%10.8%11.7%9.3%14.7%
Other Income 0000.1600.260.220.643.623.52
Interest 00000.051.971.892.854.967.40
Depreciation 000000.400.340.931.451.02
Exceptional Items 00000-4.110-0.5000
Profit Before Tax -0.13-0.10-0.12-0.05-0.21-10.894.235.083.010.65
Tax 00000000.021.55-0.80
Profit After Tax -0.13-0.10-0.12-0.05-0.21-10.894.235.061.461.45
PAT Margin (%) -----41.0%-51.8%7.3%6.8%2.3%3.8%
Adjusted EPS (₹)-0.4-0.3-0.3-0.2-0.6-3.21.21.50.30.3
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 3.13-0.48-0.60-0.66-0.8619.9524.1849.6050.4051.84
Share Capital 3.643.643.643.643.6434.2334.2343.4845.5445.54
Reserves -0.52-4.12-4.25-4.30-4.50-14.28-10.056.134.866.31
Minority Interest0000000000
Debt0.400.480.600.640.6915.4316.7334.1957.3860.44
Long Term Debt0.400.480.600.640.698.156.799.7614.8813.64
Short Term Debt000007.289.9524.4342.5046.80
Trade Payables0000.010.383.426.451.562.728.56
Others Liabilities 000.010.010.011.042.0814.9415.519.84
Total Liabilities 3.5300.010.010.2239.8549.43100.30126.01130.68

Fixed Assets

Gross Block3.50000016.5317.0926.5025.8020.53
Accumulated Depreciation000001.421.762.694.143.87
Net Fixed Assets 3.50000015.1115.3323.8121.6616.66
CWIP 0000013.7213.2212.7218.0318.09
Investments 000000.190.197.999.569.61
Inventories000001.081.371.861.921.69
Trade Receivables00000.084.7712.8816.2317.6016.46
Cash Equivalents 0.0300.010.010.080.631.450.620.260.06
Others Assets 00000.064.355.0137.0856.9868.11
Total Assets 3.5300.010.010.2239.8549.43100.30126.01130.68

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity -0.13-0.10-0.12-0.210.080.523.478.3326.0917.35
PBT -0.13-0.10-0.12-0.05-0.21-10.894.235.063.010.65
Adjustment 000-0.160.054.472.214.186.238.25
Changes in Working Capital -0.0100.010.010.236.94-2.97-0.9116.858.46
Tax Paid 0000000000
Cash Flow From Investing Activity 00000-0.560.59-14.09-7.26-1.34
Capex 00000-0.37-0.06-1.90-6.34-0.85
Net Investments 00000-0.170-7.80-1.57-0.06
Others 00000-0.020.65-4.390.66-0.43
Cash Flow From Financing Activity 0.140.080.130.200-0.73-3.234.93-19.19-16.22
Net Proceeds from Shares 000000021.744.630
Net Proceeds from Borrowing 000.130.0400005.12-1.24
Interest Paid 00000-1.96-1.88-2.23-4.83-7.32
Dividend Paid 0000000000
Others 0.140.0800.1601.23-1.35-14.58-24.11-7.66
Net Cash Flow 0.01-0.030.01-00.08-0.780.82-0.83-0.36-0.20

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)-4.05N/AN/AN/AN/A-114.0619.1515.673.212.83
ROCE (%)-3.67N/AN/AN/AN/A-50.6516.0312.457.996.99
Asset Turnover Ratio00004.441.051.30.990.550.29
PAT to CFO Conversion(x)N/AN/AN/AN/AN/AN/A0.821.6517.8711.97
Working Capital Days
Receivable Days00005642567199165
Inventory Days0000019881117
Payable Days000014244453522139

Indrayani Biotech Ltd Stock News

Indrayani Biotech Ltd FAQs

The current trading price of Indrayani Biotech on 05-Dec-2025 16:59 is ₹14.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Indrayani Biotech stood at ₹63.75.
The latest P/E ratio of Indrayani Biotech as of 04-Dec-2025 is 44.18.
The latest P/B ratio of Indrayani Biotech as of 04-Dec-2025 is 1.23.
The 52-week high of Indrayani Biotech is ₹37.99 and the 52-week low is ₹10.20.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Indrayani Biotech is ₹33.66 ( Cr.) .

About Indrayani Biotech Ltd

The company was incorporated on March 9, 1992 and it was converted into a public limited company on March 13, 1992. It is into floriculture and is engaged in the cultivation of cut flowers, plantlets and seeds.

Indrayani Biotech produces cut flowers, strawberries, tissue culture plantlets and hybrid vegetable seeds. The company has also started marketing and distribution and extensive field demonstrations of hybrid vegetable seeds manufactured by HOECHST India. Technical agreements have been signed with Floral Max, Malaysia for rose cultivation and with B. L. McKenzie and Associates, New Zealand for tissue culture. The planting material for strawberries has been acquired from the US. Indrayani Biotech has signed a test agreement with the technology transfer offer of the University of California to obtain certified planting material from nurseries in California.

Indrayani Biotech started exporting flowers to Holland and Dubai in 1994-1995. Restricted water supply and changes in ecology resulted in a shortfall in achieving its goals. In 1995-1996, the company incurred losses due to insufficient water supply, labor problems and sub-standard infrastructure. To overcome the above problems, the company is considering shifting its green houses to alternate locations.

The company has installed five Greenhouses and plantation in these greenhouses is complete.  A pilot tissue culture laboratory is also completed and the protocol to be used in manufacture of tissue culture plantlets is being perfected. 

The company’s registered office and factory are located at Pune, India.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×